Ventas (NYSE:VTR) Hits New 1-Year High – Here’s What Happened

Shares of Ventas, Inc. (NYSE:VTRGet Free Report) reached a new 52-week high during trading on Wednesday . The stock traded as high as $94.84 and last traded at $92.5450, with a volume of 1257032 shares traded. The stock had previously closed at $92.40.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price objective on shares of Ventas in a research note on Tuesday, June 16th. Raymond James Financial started coverage on shares of Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 price target on the stock. BMO Capital Markets reaffirmed an “outperform” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, May 4th. Royal Bank Of Canada increased their price objective on Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, May 4th. Finally, KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Ventas has a consensus rating of “Moderate Buy” and a consensus target price of $96.17.

Get Our Latest Research Report on VTR

Ventas Stock Up 2.9%

The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The business’s fifty day moving average price is $87.09 and its two-hundred day moving average price is $84.07. The firm has a market cap of $46.18 billion, a P/E ratio of 172.72, a P/E/G ratio of 1.98 and a beta of 0.70.

Ventas (NYSE:VTRGet Free Report) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities research analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. The ex-dividend date was Tuesday, June 30th. Ventas’s dividend payout ratio is 378.18%.

Insider Transactions at Ventas

In related news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were bought at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. This represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.53% of the company’s stock.

Institutional Trading of Ventas

Several large investors have recently modified their holdings of the company. Angeles Wealth Management LLC grew its position in shares of Ventas by 4.0% in the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock valued at $274,000 after purchasing an additional 128 shares during the last quarter. Bridgewater Advisors Inc. lifted its position in shares of Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares during the last quarter. IHT Wealth Management LLC boosted its stake in Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after purchasing an additional 137 shares during the period. True Wealth Design LLC grew its holdings in Ventas by 32.0% in the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after buying an additional 138 shares during the last quarter. Finally, Cigna Investments Inc. New increased its position in Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after buying an additional 142 shares during the period. 94.18% of the stock is owned by institutional investors.

About Ventas

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Read More

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.